UNICYCIVE THERAPEUTICS, INC. (UNCY) Operating income 2020–2025
UNICYCIVE THERAPEUTICS, INC. (UNCY) annual operating income history from SEC filings — each fiscal year as reported.
-$29.5MFY2025 · since FY2020: -$2.0M → -$29.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.5M | +8.1% |
| FY2024 | -$32.1M | -54.6% |
| FY2023 | -$20.8M | -15.1% |
| FY2022 | -$18.1M | -101.1% |
| FY2021 | -$9.0M | -344.4% |
| FY2020 | -$2.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More UNCY financial trends
UNCY RevenueUNCY Net incomeUNCY Net marginUNCY Gross profitUNCY Gross marginUNCY Operating marginUNCY Operating cash flowUNCY Free cash flowUNCY Capital expendituresUNCY Return on equityUNCY Stock buybacksUNCY Dividends paidUNCY Total assetsUNCY Total liabilitiesUNCY Shareholders’ equityUNCY overview →